Navigating rheumatoid arthritis: insights into ligand-anchored nanoparticle strategies for anti-inflammatory therapy and relief
RSC Pharmaceutics · 2025 · 2 (1) · 19-43
DOI: 10.1039/d4pm00133h ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2025. Verfasst von Shriya Karmarkar und 4 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Ligand-based nanotechnology is promising in enhancing targeted drug delivery in autoimmune disorders. This study explores molecular targets and new active targeting techniques. These technologies enhance drug specificity via precise targeting.
Zitieren
APA
Karmarkar, S., Fernandes, T., Choonia, Z., Gharat, S., & Sawarkar, S. (2025). Navigating rheumatoid arthritis: insights into ligand-anchored nanoparticle strategies for anti-inflammatory therapy and relief. RSC Pharmaceutics, 2(1), 19-43. https://doi.org/10.1039/d4pm00133h
Vancouver
Karmarkar S, Fernandes T, Choonia Z, Gharat S, Sawarkar S. Navigating rheumatoid arthritis: insights into ligand-anchored nanoparticle strategies for anti-inflammatory therapy and relief. RSC Pharmaceutics. 2025;2(1):19-43. doi:10.1039/d4pm00133h
BibTeX
@article{Karmarkar2025,
author = {Karmarkar, Shriya and Fernandes, Trinette and Choonia, Zainab and Gharat, Sankalp and Sawarkar, Sujata},
title = {Navigating rheumatoid arthritis: insights into ligand-anchored nanoparticle strategies for anti-inflammatory therapy and relief},
journal = {RSC Pharmaceutics},
year = {2025},
volume = {2},
number = {1},
pages = {19--43},
doi = {10.1039/d4pm00133h}
}
EUVIMED